Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
Globenewswire· 2025-08-26 12:30
Company to Advance Development of its Patented DeviceLAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-saving medical products is pleased to provide the following update on the development of its Save A Life (“SAL”) choking rescue device. Odyssey has created a prototype device and now plans to continue the advancement of the product with the ultimate goal of filing a subm ...
DeFi Development Corp. Joins Global Dollar Network, Expanding Access to USDG Stablecoin
Globenewswire· 2025-08-26 12:30
Company Overview - DeFi Development Corp. (Nasdaq: DFDV) is the first US public company with a treasury strategy focused on accumulating and compounding Solana (SOL) [1] - The company has adopted a treasury policy where the principal holding in its treasury reserve is allocated to SOL, providing investors with direct economic exposure to SOL [4] Partnership and Integration - DeFi Development Corp. has joined the Global Dollar Network (GDN), which is recognized as the world's fastest-growing stablecoin network [1][7] - The partnership allows DFDV to expand the availability and utility of USDG, a US dollar-backed stablecoin, across the Solana ecosystem [3][4] - DFDV will participate in governance through the GDN Network Advisory Committee, influencing USDG adoption and strategy [8] Economic Model and Benefits - GDN's unique economic framework distributes network revenue to partners based on their contributions, promoting collaboration and adoption [2][7] - USDG is managed by Paxos Digital Singapore, ensuring it maintains a 1:1 parity with the US dollar, allowing consumers to redeem tokens for fiat at all times [2] Market Position and Strategy - The company operates its own validator infrastructure, generating staking rewards and fees from delegated stake, while also exploring decentralized finance (DeFi) opportunities [4] - DFDV aims to lead USDG adoption on Solana, integrating compliant, institutional-grade stable value into the ecosystem [4]
SOLOWIN Invests in Leading Web 3 Media Outlet ME Group
Globenewswire· 2025-08-26 12:30
Core Insights - Solowin Holdings has made a strategic investment in MetaEra, now rebranded as ME, a prominent Web 3 industry news platform focused on brand growth strategies [1][3] - The Pre-Series A funding round was co-led by Fenbushi Inc. and Hashkey Capital, with participation from Solowin and other institutional investors [1] Company Overview - Solowin Holdings (NASDAQ: SWIN) is a leading global financial services firm that operates in both traditional and Web 3 industries, established in 2016 [4] - The company has developed a full-spectrum ecosystem that bridges traditional finance and decentralized finance, leveraging its licensed subsidiaries for digital asset capabilities [4] ME's Business Model - ME operates three core business divisions: media services (ME Media), event planning (ME Event), and AI-driven data services (ME AI) [2] - The newly launched platform CoinFound offers innovative solutions such as real-world asset pricing data, on-chain analytics, and AI-generated research reports [2] Strategic Alignment - The investment in ME aligns with Solowin's focus on building a digital finance ecosystem, enhancing transparency and professionalization in Web 3 financial information [3] - Proceeds from the funding round will be allocated to AI technology development and global market expansion for ME [3]
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
Globenewswire· 2025-08-26 12:30
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial dataNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announces that it has successfully identified a new biological target and novel therapeutic indication for its lead programme, AZD1656 (and its derivatives), following positive data from pre-clinical studies. This affirms the Company ...
ZenaTech Signs Offer to Acquire a UK Telecom Sector 3D Design & Modeling Company, Expanding Drone as a Service European Footprint
Globenewswire· 2025-08-26 12:15
Core Insights - ZenaTech, Inc. has signed an offer to acquire a UK-based 3D design and modeling company, marking its first expansion of Drone as a Service (DaaS) into the UK market [1][2] - The acquisition aims to enhance ZenaTech's strategic international footprint in Europe and create new opportunities in the telecommunications and infrastructure sectors [1][2] - The target company specializes in advanced 3D scanning, modeling, and design services for telecom infrastructure, which aligns with ZenaTech's focus on drone-enabled solutions [2][3] Company Strategy - ZenaTech's acquisition strategy focuses on modernizing traditional surveying and inspection businesses by integrating AI drone technology, which is expected to accelerate market adoption and expand the client base [3] - The company has completed eight acquisitions and aims to establish 25 DaaS locations by mid-2026, providing flexible access to advanced drone services for various sectors [4] Market Context - The telecommunications sector is undergoing significant transformation with the modernization of 5G infrastructure, creating opportunities for drone-based solutions to enhance efficiency and safety [2] - ZenaTech's DaaS model eliminates the need for clients to invest in drone hardware and software, making it an attractive option for businesses and government clients [4][5]
Ocean Power Technologies Accelerates UAE Growth Strategy Through Expanded Partnership with Unique Group
Globenewswire· 2025-08-26 12:15
Core Insights - Ocean Power Technologies, Inc. (OPT) has entered into a Master Services Agreement (MSA) with Unique Group to enhance collaboration on unmanned surface vehicle (USV) projects in the UAE [1][2] - The MSA aims to accelerate WAM-V deployments and convert interest into revenue while scaling recurring lease income without significant overhead [2][4] - Unique Group will lease one OPT WAM-V 22 USV immediately, with plans for revenue sharing and joint fleet expansion [3][4] Group 1 - The MSA formalizes and expands the strategic collaboration originally announced in July 2024, positioning Unique Group as OPT's execution partner for non-defense WAM-V USV projects in the UAE [2] - The agreement includes plans for OPT to establish a dedicated Maintenance, Repair, and Overhaul (MRO) hub in the UAE to support regional operations [3] - The partnership reflects mutual confidence in advancing maritime autonomy and aims to reduce operational risks, carbon emissions, and costs [4] Group 2 - Ocean Power Technologies provides intelligent maritime solutions for various sectors, including defense, oil and gas, and offshore wind [6] - The company's offerings include AI-integrated systems and clean energy solutions, such as the PowerBuoy® platforms and WAM-V® autonomous surface vessels [6] - The headquarters is located in Monroe Township, New Jersey, with an additional office in Richmond, California [6]
TRESU Investment Holding A/S – Announcement of Q2 2025 Interim Report
Globenewswire· 2025-08-26 12:13
Core Points - TRESU Investment Holding A/S has announced the publication of its Q2 2025 Interim Report and financial results presentation [1][2] - The financial results call is scheduled for September 5, 2025, at 10 am CET, hosted by CEO/CFO Stephan Plenz [2] - A recording of the results call will be available for four hours on the TRESU IR website [2] Company Information - The Interim Report will be presented by CEO/CFO Stephan Plenz, followed by a Q&A session [2] - Interested participants must register for the investor call by emailing the Financial Manager, Finn Holm, by September 4, 2025, at 9 am CET [2] - For further inquiries, contact CEO Stephan Plenz directly via phone [2]
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
Globenewswire· 2025-08-26 12:05
Core Insights - Clearside Biomedical is showcasing its SCS Microinjector platform and CLS-AX program at the 25th EURETINA Congress, highlighting its potential for treating multiple retinal diseases [1][3] Group 1: SCS Microinjector Platform - The SCS delivery platform is designed for targeted treatment of retinal diseases such as wet AMD, diabetic retinopathy, and ocular cancer [2] - The SCS Microinjector allows for the delivery of various drug candidates into the suprachoroidal space, aiming to improve efficacy and reduce toxic effects on non-diseased cells [8][9] Group 2: CLS-AX Program - CLS-AX is a proprietary suspension of axitinib for suprachoroidal injection, which may offer advantages over existing retinal therapies by achieving pan-VEGF blockade [6][7] - The program includes a Phase 3 trial for wet AMD and a streamlined Phase 2 trial for non-proliferative diabetic retinopathy [3] Group 3: Upcoming Presentations - Dr. Sobha Sivaprasad will present Phase 2b results from the ODYSSEY trial and updates on the Phase 3 program for neovascular age-related macular degeneration [4] - Victor Chong will discuss the evolution of suprachoroidal drug delivery and participate in a panel at the Ophthalmology Futures Retina Forum [5]
Adagene to Participate in Two Investor Conferences in September
Globenewswire· 2025-08-26 12:05
Company Overview - Adagene Inc. is a clinical-stage biotechnology company focused on developing novel antibody-based cancer immunotherapies, utilizing computational biology and artificial intelligence to address unmet patient needs [3][4] - The company has established strategic collaborations with global partners to leverage its SAFEbody precision masking technology [3] Technology and Pipeline - Adagene's proprietary Dynamic Precision Library (DPL) platform includes NEObody™, SAFEbody, and POWERbody™ technologies, which are designed to enhance the safety and efficacy of antibody therapeutics [4] - The SAFEbody technology specifically targets the tumor microenvironment, allowing for tumor-specific antibody targeting while minimizing toxicity to healthy tissues [4] Clinical Programs - The lead clinical program, ADG126 (muzastotug), is a masked anti-CTLA-4 SAFEbody currently in phase 1b/2 clinical studies, focusing on Metastatic Microsatellite-stable (MSS) Colorectal Cancer in combination with anti-PD-1 therapy [5] - The SAFEbody platform is validated for use across various antibody-based therapeutic modalities, including Fc empowered antibodies and antibody-drug conjugates [5] Investor Engagement - Adagene's Chief Strategy Officer will participate in one-on-one investor meetings and a fireside chat at two upcoming investor conferences in New York in September [1][2] - Webcasts of the presentations will be available on the company's website for at least 30 days [2]
FTC Solar Announces 1GW Tracker Agreement with Levona Renewables
Globenewswire· 2025-08-26 12:04
Core Insights - FTC Solar, Inc. has entered into an agreement with Levona Renewables to supply solar trackers and software for one gigawatt of solar projects starting in early 2026 [1][2] - The first project under this agreement, CT Solar One, will be a 140-megawatt facility in Snyder, Texas, with construction expected to begin in early 2026 [2] - The overall site development will include additional projects, CT Solar Two and CT Solar Three, adding approximately 650 megawatts [2] Company Overview - FTC Solar, founded in 2017, specializes in solar tracker systems, technology, software, and engineering services, enhancing energy production by optimizing solar panel orientation [4] - The company offers a robust product lineup, including high-wind and terrain-following trackers, along with performance-enhancing software [3][4] Partnership Dynamics - Levona Renewables has praised FTC Solar for its collaborative approach and expertise, which has added significant value to their development projects [3] - The partnership aims to optimize site layout, energy yield, and construction efficiency, minimizing civil costs [3]